The Voice of the Hematological Malignancy Patient: Are You Listening?

Discover a groundbreaking webinar delving into the importance of patient-centricity in hematological malignancy clinical trials. At the heart of every therapeutic breakthrough are patients — and their loved ones — whose noble contributions to medical research pave the path to market for innovative treatments that improve outcomes and quality of life. In hematological malignancies — where global incidence is increasing and the median age for most diseases is 65-70 years of age — a patient-centered mindset is essential for addressing and overcoming barriers to clinical trial participation for this fragile patient population.

Increasingly, sponsors and regulators are emphasizing the importance of enhancing the patient experience in clinical trials to increase participation and generate meaningful data that truly reflects patients’ needs and preferences. When implemented successfully, patient-centric strategies promote higher engagement and, ultimately, improved healthcare outcomes.

Join this webinar to gain insights into:

• Drivers and benefits of patient centricity in the clinical trial landscape
• Why patient-centric approaches are important in populations with hematological malignancies
• Regulatory perspectives on the patient experience in clinical trials
• How to design and execute patient-centric hematological malignancy clinical trials, with real-life examples

Speaker

Ashley Herrick, PhD, Executive Director, Oncology Program Strategy, Premier Research

Dr. Ashley Herrick provides strategic planning, coordination, knowledge and expertise for oncology projects. She has more than 13 years of experience in oncology clinical trial oversight and drug development. She has experience with all phases of clinical trials but has a keen interest and deep knowledge of early phase and first-in-man studies. She has led numerous global clinical trials and has experience with strategic management, study oversight, study start-up, efficient enrollment and study close-out/CSR development.

Prior to joining Premier Research, Dr. Herrick was Director of Operational Strategy Management for a mid-sized CRO overseeing the strategic planning for studies. She also supported their oncology site network and was responsible for oversight of a biomarker-driven patient matching group. She has also served as Project Director, Project Manager and CRA throughout her years working in the CRO industry and has devoted her entire career to oncology research. Prior to joining the CRO industry, she worked as a Program Manager for the largest Phase I clinical trial unit in the country at MD Anderson Cancer Center, where she was responsible for oversight of more than 50 industry-sponsored and investigator-led Phase I clinical trials.

Read more...

Dr. Herrick holds a doctorate degree in molecular and cellular biology with a focus on hematologic malignancies from Baylor College of Medicine. She is CCRP certified and is a member of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). She is an active volunteer with the Leukemia and Lymphoma Society (LLS).

Read Less...

Message Presenter